Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-02

Clinical Trial Update: A Double Blind Study Performed to Evaluate the Efficacy and the Safety of EscharEx in Debridement of VLU (VALUE) [Phase 3]

View source ↗

Summary

A Phase 3 double-blind trial is evaluating the efficacy and safety of EscharEx for debridement of venous leg ulcers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EscharEx (EX-03 formulation)

Snippet

Sponsor: MediWound Ltd | Conditions: Venous Leg Ulcer (VLU) | Phase 3 | Status: RECRUITING